Tenofovir Disoproxil Fumarate (Tenofovir DF) Versus Emtricitabine/Tenofovir DF in Subjects Resistant to Lamivudine

NCT00737568 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

280

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B

Interventions

DRUG: TDF
DRUG: FTC/TDF
DRUG: TDF Placebo
DRUG: FTC/TDF Placebo

Sponsor

Gilead Sciences